COVID-19 Infection and Previous BCG Vaccination Coverage in the Ecuadorian Population
Open Access
- 27 January 2021
- Vol. 9 (2), 91
- https://doi.org/10.3390/vaccines9020091
Abstract
The Bacillus Calmette–Guérin (BCG) is a well-known vaccine with almost a century of use, with the apparent capability to improve cytokine production and epigenetics changes that could develop a better response to pathogens. It has been postulated that BCG protection against SARS-CoV-2 has a potential role in the pandemic, through the presence of homologous amino acid sequences. To identify a possible link between BCG vaccination coverage and COVID-19 cases, we used official epidemic data and Ecuadorian Ministry of Health and Pan American Health Organization vaccination information. BCG information before 1979 was available only at a national level. Therefore, projections based on the last 20 years were performed, to compare by specific geographic units. We used a Mann–Kendall test to identify BCG coverage variations, and mapping was conducted with a free geographic information system (QGIS). Nine provinces where BCG vaccine coverage was lower than 74.25% show a significant statistical association (χ2 Pearson’s = 4.800, df = 1, p = 0.028), with a higher prevalence of cases for people aged 50 to 64 years than in younger people aged 20 to 49 years. Despite the availability of BCG vaccination data and the mathematical models needed to compare these data with COVID-19 cases, our results show that, in geographic areas where BCG coverage was low, 50% presented a high prevalence of COVID-19 cases that were young; thus, low-coverage years were more affected.This publication has 39 references indexed in Scilit:
- BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained ImmunityCell Host & Microbe, 2018
- Bacillus Calmette–Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell ResponsesThe Journal of Immunology, 2016
- Summary and Recommendations from the National Cancer Institute’s Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder CancerBladder Cancer, 2016
- Trained immunity: A program of innate immune memory in health and diseaseScience, 2016
- Management and outcome of Bacille Calmette-Guérin vaccine adverse reactionsVaccine, 2015
- Global Epidemiology of TuberculosisCold Spring Harbor Perspectives in Medicine, 2014
- DOTS strategy and community participation: an experience in the Ecuadorian Andes.2009
- Global epidemiology of tuberculosisThe Lancet, 2006
- BCG VaccineAdvances in experimental medicine and biology, 2004
- Relationship Between Bacille Calmette-Guerin (BCG) Strains and the Efficacy of BCG Vaccine in the Prevention of TuberculosisClinical Infectious Diseases, 1995